BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lin C, Li ZL, Cai XL, Hu SY, Lv F, Yang WJ, Ji LN. Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysis. World J Diabetes 2023; 14(10): 1573-1584 [PMID: 37970134 DOI: 10.4239/wjd.v14.i10.1573]
URL: https://www.wjgnet.com/1948-9358/full/v14/i10/1573.htm
Number Citing Articles
1
Kotha Sugunakar Reddy, Archana Gaur, Sakthivadivel Varatharajan, Arvind Kumar Morya. Chiglitazar and Thiazolidinedione in patients with type 2 diabetes: Which is better?World Journal of Diabetes 2024; 15(3): 565-567 doi: 10.4239/wjd.v15.i3.565
2
Sujun Xiao, Mingxu Qi, Qinyi Zhou, Huiqin Gong, Duhui Wei, Guangneng Wang, Qilun Feng, Zhou Wang, Zhe Liu, Yiren Zhou, Xiaofeng Ma. Macrophage fatty acid oxidation in atherosclerosisBiomedicine & Pharmacotherapy 2024; 170: 116092 doi: 10.1016/j.biopha.2023.116092